By Chris Wack Centogene N.V. said Tuesday that it has extended its partnership with Takeda Pharmaceutical Co. to diagnose patients with Lysosomal Storage Disorders. Under the renewed. | April 11, 2023
Centogene (NASDAQ:CNTG – Get Rating) was the target of a large growth in short interest during the month of March. As of March 15th, there was short interest totalling 4,000 shares, a growth of 11.1% from the February 28th total of 3,600 shares. Approximately 0.0% of the company’s stock are short sold. Based on an […]
Combining expertise to advance precision medicine, while enabling efficient and timely insights into the diagnosis of rare diseases and hereditary cancer around the world Twist Bioscience Corporation
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 22, 2022 (GLOBE NEWSWIRE) Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative
CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Dec. 16, 2022 (GLOBE NEWSWIRE) Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative